World's most expensive medicine Glybera goes on sale with $1.4 million price tag - (The Guardian via NewsPoints Desk)

  • UniQure and Chiesi's gene therapy Glybera for lipoprotein lipase deficiency (LPLD) is set to go on sale in Germany at a cost of 1.1 million euros ($1.4 million), as reported Thursday in The Guardian.
  • Glybera was approved in Europe two years ago, but its launch has been delayed to allow for the collection of follow-up data on its benefits.
  • Chiesi has now filed a pricing dossier with Germany's federal joint committee (G-BA), which will issue an assessment of the drug’s benefits by the end of April next year.
  • Under German rules, the launch price for a new drug is valid for the first 12 months, with each vial of Glybera having a retail price of 53,000 euros per vial.
  • A Chiesi spokeswoman noted that a final figure would be set after the G-BA gives its verdict and negotiations are held with statutory health insurance funds, adding that "first commercial treatments are expected in the first half 2015."
  • UniQure, which will get a net royalty of between 23 percent and 30 percent on sales, also has plans to seek approval for Glybera in the US, which it hopes to get in 2018.

To read more NewsPoints articles, click here.